UNLIKELY LEADERS: THE BATTLE OF DEVELOPING COUNTRIES TO ACCESS PATENTED MEDICATIONS

UNLIKELY LEADERS: THE BATTLE OF DEVELOPING COUNTRIES TO ACCESS PATENTED MEDICATIONS

LÍDERES IMPROVÁVEIS: A BATALHA DOS PAÍSES EM DESENVOLVIMENTO PELO ACESSO A MEDICAMENTOS PATENTEADOS

In negotiations with large laboratories, governments of large non-innovative countries would have greater bargaining power than the governments of the innovative giants among emerging countries. How is this possible? The answer is that only large non-innovative countries can employ a strategy to overcome patent medication protection under the TRIPS Agreement.